Platelets have long been recognized to be of central importance in haemostasis, but their participation in pathological conditions such as thrombosis, atherosclerosis and inflammation is now also well established. The platelet has therefore become a key target in therapies to combat cardiovascular disease. Anti-platelet therapies are used widely, but current approaches lack efficacy in a proportion of patients, and are associated with side effects including problem bleeding. In the last decad...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Future innovations in anti-platelet therapies.
If you are the owner of this record, you can report an update to it here: Report update to this record